Abstract
Over the last few years, polymeric micelles have been praised for their versatility, biocompatibility, and biodegradability. A large number of polymers has been developed to improve the pharmacokinetics of a plethora of poorly soluble drugs but also peptides, DNA, and RNA fragments. Polymeric micelles demonstrated their high loading capacity, stability in the blood circulation, longevity, and enhanced tumor accumulation in tumor tissues through passive or active targeting. This chapter summarized the recent efforts in the development of polymeric micelles for the treatment of lung cancers in preclinical studies and in clinical trials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
